Garenoxacin as a prophylactic anti-infective in hydropneumothorax: a case study report.

Simple item page
dc.contributor.authorHaider, Shahid
dc.contributor.authorHajare, Anoop L
dc.contributor.authorKrishnaprasad, K
dc.contributor.authorBhargava, Amit
dc.date.accessioned2015-11-04T11:30:33Z
dc.date.available2015-11-04T11:30:33Z
dc.date.issued2015-03
dc.description.abstractPneumothorax appears to be a common clinical state. Iatrogenic pneumothorax occurs commonly after procedures such as transthoracic needle biopsy, pleural biopsy, positive pressure ventilation, etc. Diagnosis of iatrogenic pneumothorax is often delayed. Broad spectrum anti-infectives appear to be benefi cial in reducing the infections, especially when chest drains are inserted. Garenoxacin, a potent quinolone with its unique structural modifi cation appears to have an edge over other respiratory quinolones.en_US
dc.identifier.citationHaider Shahid, Hajare Anoop L, Krishnaprasad K, Bhargava Amit. Garenoxacin as a prophylactic anti-infective in hydropneumothorax: a case study report. International Journal of Basic & Clinical Pharmacology. 2015 Mar-Apr; 4(2): 385-387.en_US
dc.identifier.issn2319-2003
dc.identifier.issn2279-0780
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/165084
dc.language.isoenen_US
dc.source.urihttps://www.ijbcp.com/?mno=180218en_US
dc.subjectPneumothoraxen_US
dc.subjectIatrogenicen_US
dc.subjectGarenoxacinen_US
dc.subjectChest drainen_US
dc.titleGarenoxacin as a prophylactic anti-infective in hydropneumothorax: a case study report.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijbcp2015v4n2p385.pdf
Size:
161.81 KB
Format:
Adobe Portable Document Format
Description:
Case report
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
International Journal of Basic & Clinical Pharmacology